4 employees
Matridx focuses on molecular diagnostic technology for infectious pathogens.
2019
Hangzhou Matridx Biotechnology Co Ltd raised undisclosed on September 26, 2021
Investors: 华泰紫金投资有限责任公司 and QianHai FoFs